APP Pharmaceuticals has issued a voluntary recall of five lots of irinotecan HCl injection due to the discovery of foreign particulate material and nonsterility in one lot.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.